Myricx Bio

Healthcare

HQ: London, United Kingdom

Investors: 1

Develops N-myristoyltransferase inhibitors for cancer treatment

Investors (1)

Fund	Status	Entry Date	Stage	Source
Sofinnova Partners	Current	-	-	Website

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.